4//SEC Filing
Koppikar Utpal 4
Accession 0001209191-21-065717
CIK 0001419600other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 10:13 AM ET
Size
6.5 KB
Accession
0001209191-21-065717
Insider Transaction Report
Form 4
Koppikar Utpal
Director
Transactions
- Disposition to Issuer
Stock option (right to buy)
2021-11-19−32,000→ 0 totalExercise: $7.82Exp: 2031-07-08→ Common Stock (32,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. ("Issuer"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. ("Purchaser") ("Merger Agreement"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation ("Merger").
- [F2]At the effective time of the Merger, each outstanding option with an exercise price less than $8.50 per share was accelerated and became fully vested and exercisable and was cancelled and converted into the right to receive (i) cash in an amount equal to the product of (a) the total number of shares of Issuer common stock subject to such option multiplied by (b) the excess of (x) $8.50 per share over (y) the exercise price payable per share of Issuer common stock under such option, and (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001742696
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 10:13 AM ET
- Size
- 6.5 KB